Pomdoctor Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	399.92	342.56	304.85	245.22	215.39
Revenue Growth (YoY)	16.74%	12.37%	24.32%	13.85%	52.53%
Cost of Revenue	347.63	294.86	266.13	190.36	162.88
Gross Profit	52.28	47.69	38.72	54.86	52.51
Selling, General & Admin	155.94	68.24	55.99	54.87	102.95
Research & Development	12.86	3	3.37	3.59	4.28
Other Operating Expenses	2.11	2.24	1.61	-	24.94
Total Operating Expenses	170.92	73.49	60.97	58.46	132.18
Operating Income	-118.64	-25.79	-22.25	-3.59	-79.67
Interest Expense	-12.89	-12.96	-13.85	-16.02	-16.29
Other Non-Operating Income (Expense)	0.59	1.39	-0.85	-0.21	-0.22
Total Non-Operating Income (Expense)	-12.3	-11.57	-14.7	-16.24	-16.51
Pretax Income	-130.93	-37.37	-36.95	-19.83	-96.18
Provision for Income Taxes	-0	-	-	-	-
Net Income	-130.93	-37.37	-36.95	-19.83	-96.18
Net Income Attributable to Preferred Dividends	81.65	105.97	108.44	105.68	92.24
Net Income to Common	-212.58	-143.36	-145.39	-125.51	-188.4
Shares Outstanding (Basic)	58	38	38	24	24
Shares Outstanding (Diluted)	58	38	38	24	24
Shares Change (YoY)	53.41%	-	56.11%	-	-76.35%
EPS (Basic)	-3.66	-3.79	-3.84	-5.17	-7.77
EPS (Diluted)	-3.66	-3.79	-3.84	-5.17	-7.77
Free Cash Flow	-149.49	-16.17	-45.91	-22.02	-15.68
Free Cash Flow Per Share	-2.57	-0.43	-1.21	-0.91	-0.65
Gross Margin	13.07%	13.92%	12.70%	22.37%	24.38%
Operating Margin	-29.67%	-7.53%	-7.30%	-1.47%	-36.99%
Profit Margin	-32.74%	-10.91%	-12.12%	-8.09%	-44.66%
FCF Margin	-37.38%	-4.72%	-15.06%	-8.98%	-7.28%
EBITDA	-118.49	-25.66	-22.14	-3.59	-61.99
EBITDA Margin	-29.63%	-7.49%	-7.26%	-1.47%	-28.78%
EBIT	-118.64	-25.79	-22.25	-3.59	-79.67
EBIT Margin	-29.67%	-7.53%	-7.30%	-1.47%	-36.99%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q